Brind.

Schrödinger plans to meet with the FDA to discuss the Phase 2 dose of a drug.

1 report, 1 independent Updated Aug 7

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Schrödinger FDA

Keep exploring

The entities involved

Schrödinger
American life sciences company

Nothing else this week.
FDA
- A couple in Newfane, NY, faces drug oversight issues while Lucas is in Niagara County rehab.17:28
- FDA took action against facilities in Bhiwandi, inspected Khed warehouses, and found food safety violations at Reliance Retail in Pune.15:59

Coverage

Newest first; wire copies grouped

Aug 7Business WireSchrödinger Reports Second Quarter 2025 Financial Results Second Quarter Total Revenue of $54.8 Million, Software Revenue of $40.5 Million Maintains Full Year 2025 Revenue Growth Guidance and Lowers